Exchange: OTC·Updated 04:00 PM EDT

CSLLY Csl ADR

$30.72
$0.81
(2.71%)
Today
Closed $30.72
$0.00
(0.00%)
After Hours
EarningsFeb 9
Mkt Cap$58.97B
Vol86,773.00

About CSLLY

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment provides plasma products, gene therapies, and recombinants. The CSL Seqirus segment includes predominantly influenza related products and provides pandemic services to governments. The CSL Vidor segment focuses on the distribution of products in the therapeutic areas of iron deficiency and nephrology. The company was founded on November 2, 1961 and is headquartered in Melbourne, Australia.
50

Neutral Sentiment

How do you feel about CSLLY?

Advertisement|Remove ads.